Insider Transactions in Q1 2023 at Miromatrix Medical Inc. (MIRO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
31,250
+7.31%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
31,250
+37.88%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Lisa Wipperman Heine |
BUY
Open market or private purchase
|
Direct |
31,250
+28.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
William P. Burke Mr. |
BUY
Open market or private purchase
|
Direct |
31,250
+28.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
John L Erb |
BUY
Open market or private purchase
|
Direct |
31,250
+35.71%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Peter Maag |
BUY
Open market or private purchase
|
Direct |
31,250
+32.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Paul Buckman |
BUY
Open market or private purchase
|
Indirect |
31,250
+37.27%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Open market or private purchase
|
Direct |
6,250
+14.98%
|
$6,250
$1.6 P/Share
|
|
Jan 13
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 13
2023
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+25.49%
|
-
|
|
Jan 13
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,487
-1.21%
|
$13,461
$3.26 P/Share
|
|
Jan 13
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.92%
|
-
|